Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study

Frontiers in Bioengineering and Biotechnology

Xuan Yu¹  Kai Li¹  Songsong Wu²  Dezhi Zhang³  Qiang Lu⁴  Jiandong Chang⁵ 

[1] Department of Medical Ultrasonics, The Third Affiliated Hospital of Sun Yat-sen University, Guangdong, China;Department of Ultrasonography, Shengli Clinical Medical College of Fujian Medical University, Fujian, China;Department of Ultrasound, The First Hospital of Jilin University, Jilin, China;Department of Ultrasound, West China Hospital, Sichuan, China;Department of Ultrasound, Xiamen Chinese Medical Hospital, Fujian, China;

关键词: focal nodular hyperplasia;    ultrasonography;    radiofrequency ablation;    microwave ablation;    thermal ablation;   

DOI  :  10.3389/fbioe.2021.826926

来源: DOAJ

【 摘 要 】

Background and Aim: To evaluate the clinical effect of ultrasound (US)-guided percutaneous thermal ablation of hepatic focal nodular hyperplasia (FNH).Methods: A retrospective analysis of the clinical data of patients undergoing US-guided percutaneous thermal ablation of FNH from November 2008 to August 2021 at five medical centers in China was conducted.Results: A total of 53 patients were included (26 males and 27 females). The mean age was 35.1 ± 10.8 years. Sixty-five lesions (46 solitary cases and 7 cases with multiple lesions) were included, 70.8% (46/65) of which were located in the right liver lobe. The mean tumor length was 2.9 ± 1.5 cm. All patients successfully completed the ablation treatment. Immediate postoperative imaging showed that the primary technical success rate was 94.3% (50/53). Two patients underwent ablation 3 and 6 months after the primary ablation, and the secondary technical success rate was 100% (2/2). The incidence of complications was 3.8% (2/53). Imaging follow-up was conducted regularly after ablation, and no residual lesion enlargement or tumor recurrence was observed during the follow-up period. The technique efficacy rate was 98.1% (52/53).Conclusion: US-guided percutaneous thermal ablation is a safe and effective treatment for FNH of the liver.

【 授权许可】

Unknown